Alice Fabbri
Alice Fabbri
Tobacco Control Research Group, Department for Health, University of Bath
Verified email at bath.ac.uk
Title
Cited by
Cited by
Year
The Influence of Industry Sponsorship on the Research Agenda: A Scoping Review
A Fabbri, A Lai, Q Grundy, LA Bero
American journal of public health 108 (11), e9-e16, 2018
752018
The risk of bias in observational studies of exposures (ROBINS-E) tool: concerns arising from application to observational studies of exposures
L Bero, N Chartres, J Diong, A Fabbri, D Ghersi, J Lam, A Lau, ...
Systematic Reviews 7 (1), 242, 2018
732018
Association of Industry Sponsorship With Outcomes of Nutrition Studies: A Systematic Review and Meta-analysis
N Chartres, A Fabbri, LA Bero
JAMA Internal Medicine 176 (12), 1769-1777, 2016
662016
Sunshine Policies and Murky Shadows in Europe: Disclosure of Pharmaceutical Industry Payments to Health Professionals in Nine European Countries
MB Fabbri A, Santos A, Mezinska S, Mulinari S
International Journal of Health Policy and Management 7 (6), 504-509, 2018
412018
Conflict of interest between professional medical societies and industry: a cross-sectional study of Italian medical societies’ websites
A Fabbri, G Gregoraci, D Tedesco, F Ferretti, F Gilardi, D Iemmi, C Lisi, ...
BMJ open 6 (6), e011124, 2016
362016
Food industry sponsorship of academic research: investigating commercial bias in the research agenda
A Fabbri, TJ Holland, LA Bero
Public health nutrition 21 (18), 3422-3430, 2018
302018
A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia
A Fabbri, Q Grundy, B Mintzes, S Swandari, R Moynihan, E Walkom, ...
BMJ open 7 (6), e016701, 2017
222017
Industry funding of patient and health consumer organisations: systematic review with meta-analysis
A Fabbri, L Parker, C Colombo, et al.
BMJ 368, 2020
192020
Study sponsorship and the nutrition research agenda: analysis of randomized controlled trials included in systematic reviews of nutrition interventions to address obesity
A Fabbri, N Chartres, G Scrinis, LA Bero
Public health nutrition 20 (7), 1306-1313, 2017
182017
Pharmaceutical Industry Funding of Health Consumer Groups in Australia: A Cross-sectional Analysis
A Fabbri, S Swandari, E Lau, A Vitry, B Mintzes
International Journal of Health Services 49 (2), 273-293, 2019
152019
The inclusion of nurses in pharmaceutical industry–sponsored events: guess who is also coming to dinner?
Q Grundy, A Fabbri, B Mintzes, S Swandari, L Bero
JAMA Internal Medicine 176 (11), 1718-1720, 2016
152016
Comparative analysis of medicines safety advisories released by Australia, Canada, the United States, and the United Kingdom
LT Perry, A Bhasale, A Fabbri, J Lexchin, L Puil, M Joarder, B Mintzes
JAMA internal medicine 179 (7), 982-984, 2019
142019
Does industry-sponsored education foster overdiagnosis and overtreatment of depression, osteoporosis and overactive bladder syndrome? An Australian cohort study
B Mintzes, S Swandari, A Fabbri, Q Grundy, R Moynihan, L Bero
BMJ Open 8 (2), e019027, 2018
132018
Study sponsorship and the nutrition research agenda: analysis of cohort studies examining the association between nutrition and obesity
A Fabbri, N Chartres, LA Bero
Public health nutrition 20 (17), 3193-3199, 2017
92017
“Asset exchange”—interactions between patient groups and pharmaceutical industry: Australian qualitative study
L Parker, A Fabbri, Q Grundy, B Mintzes, L Bero
BMJ 367, l6694, 2019
82019
Association of industry ties with outcomes of studies examining the effect of wholegrain foods on cardiovascular disease and mortality: systematic review and meta-analysis
N Chartres, A Fabbri, S McDonald, J Turton, M Allman-Farinelli, ...
BMJ Open 9 (5), e022912, 2019
82019
How do health consumer organisations in Australia manage pharmaceutical industry sponsorship? A cross-sectional study
E Lau, A Fabbri, B Mintzes
Australian Health Review 43 (4), 474-480, 2018
82018
Reporting bias in the literature on the associations of health-related behaviors and statins with cardiovascular disease and all-cause mortality
LFM de Rezende, JP Rey-López, TH de Sá, N Chartres, A Fabbri, ...
PLoS biology 16 (6), e2005761, 2018
82018
Media Coverage of the Benefits and Harms of Testing the Healthy: a protocol for a descriptive study
M O'Keeffe, A Barratt, C Maher, J Zadro, A Fabbri, M Jones, R Moynihan
BMJ open 9 (8), e029532, 2019
62019
Conflicts of interest between physicians and the pharmaceutical industry
A Fabbri, M Ardigo, L Grandori, C Reali, C Bodini, A Stefanini
A qualiquantitative study to assess medical students’ attitudes at the …, 2008
62008
The system can't perform the operation now. Try again later.
Articles 1–20